Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

3 Biotech Stocks With Major Catalysts in January

TheMotleyFool

0 0

3 Biotech Stocks With Major Catalysts in January

This January is going to be a big month for folks with fatty liver disease or need of a COVID-19 vaccine. It's also going to be a month of ups or downs for shareholders of some volatile biotech stocks.

Intercept Pharmaceuticals (NASDAQ: ICPT) and Madrigal Pharmaceuticals (NASDAQ: MDGL) have important clinical trial readouts expected this month. After an excruciatingly long wait, Novavax (NASDAQ: NVAX) could also announce some important progress with its COVID-19 vaccine.

Here's what investors want to know about upcoming binary events that could send these biotech stocks rocketing higher, or cause them to sink like a stone.

Source Fool.com

Like: 0

NVAX

Share